Explore the complete record of transactions filed by 姚大林, Director. Insider active across 1 companies, notably 昭衍新药. In total, 44 disclosures have been recorded. The latest transaction was filed on 30 September 2025 (Sale). Regulator: AMF. The full history is accessible without signup.
Yao Dalin is a Board Member of Zhaoyan New Drug. He participates in the governance of the company and in strategic decision-making. His role is crucial for the success of Zhaoyan New Drug.